TerminatedNot Applicable

NUsurface Implant Registry

Stopped: Active Implants Europe closed operations

Belgium, Germany, Israel36 participantsStarted 2019-06-01

Plain-language summary

The purpose of this active post-market surveillance clinical registry study is to further characterize the therapeutic effect, the long-term safety and effectiveness of the NUsurface® meniscus implant in the real-world post-marketing setting

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * New or current treatment with the NUsurface® meniscus implant * Evidence of a personally signed and dated informed consent document indicating that the subject (or a legally acceptable representative) has been informed of all pertinent aspects of the Registry. Exclusion Criteria: * There are no protocol exclusion criteria; all subjects who meet the inclusion criteria are eligible for enrollment.

What they're measuring

KOOS (Knee Osteoarthritis Outcome Score) Pain improvement

Timeframe: 24 months

WOMET (Western Ontario Meniscus Evaluation Tool) score improvement

Timeframe: 24 months

Trial details

NCT IDNCT03953846

SponsorActive Implants

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2023-11-01

View on ClinicalTrials.gov More Meniscus; Degeneration trials